Hepatocyte growth factor disrupts cell contact and stimulates an increase in type 3 inositol triphosphate receptor expression, intracellular calcium levels, and apoptosis of rat ovarian surface epithelial cells

被引:0
作者
Melissa R. Lail-Trecker
Carolyn E. Peluso
John J. Peluso
机构
[1] University of Connecticut Health Center,Department of Obstetrics and Gynecology
[2] University of Connecticut Health Center,Department of Physiology
来源
Endocrine | 2000年 / 12卷
关键词
Rat; ovarian surface epithelial cells; intra-cellular calcium; IP; receptor; apoptosis; hepatocyte growth factor;
D O I
暂无
中图分类号
学科分类号
摘要
The present studies revealed that hepatocyte growth factor (HGF) disrupts cell contact, increases both type 3 IP3 receptor and intracellular calcium ([Ca2+) levels and induces apoptosis of rat ovarian surface epithelial cells (ROSE-179 cells). Type 3 IP3 receptor was only increased in cells that lost cell contact. Disrupting cell contact by depleting extracellular calcium (Ca2+) also resulted in an increase in [Ca2+]i levels and an increase in apoptosis. These responses were prevented by the addition of 0.7 mM Ca2+. Actinomycin D and cyclo-heximide prevented apoptosis that resulted from Ca2+ removal. In situ hybridization studies revealed that type 3 IP3 receptor was expressed at relatively low levels by ROSE-179 cells cultured with Ca2+ but at high levels in the absence of Ca2+. ROSE-179 cells cultured in Ca2+-free medium with type 3 IP3 receptor antisense oligonucleotide lost cell contact but did not show an increase in either type 3 IP3 receptor protein, [Ca2+]i, or apoptosis. The nonsense oligonucleotide did not alter these responses to Ca2+ removal. Thus, the disruption of cell contact by either HGF or Ca2+ depletion increases the expression of type 3 IP3 receptor, which causes an increase in [Ca2+]i and the apoptotic death of ROSE-179 cells.
引用
收藏
页码:303 / 314
页数:11
相关论文
共 160 条
[1]  
Kiess W.(1998)undefined Eur. J. Endocrinol. 138 482-491
[2]  
Gallaher B.(1996)undefined Semin. Reprod. Endocrinol. 14 197-02
[3]  
Chun S. Y.(1996)undefined Endocrinology 137 1447-1456
[4]  
Eisenhauer K. M.(1996)undefined Proc. Natl. Acad. Sci. USA 93 350-3513
[5]  
Minami S.(1996)undefined Curr. Opin. Cardiol. 11 574-582
[6]  
Hsueh A. J.(1996)undefined Kidney Int. 54 S68-S74
[7]  
Chun S. Y.(1997)undefined Biochem. Pharmacol. 54 847-853
[8]  
Eisenhauer K. M.(1999)undefined Endocrinology 140 2908-2916
[9]  
Minami S.(1996)undefined Endocrinology 137 1196-1203
[10]  
Billig H.(1997)undefined Endocrinology 138 107-113